183 related articles for article (PubMed ID: 1750430)
21. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.
Wheeler C; Antin JH; Churchill WH; Come SE; Smith BR; Bubley GJ; Rosenthal DS; Rappaport JM; Ault KA; Schnipper LE
J Clin Oncol; 1990 Apr; 8(4):648-56. PubMed ID: 2313334
[TBL] [Abstract][Full Text] [Related]
22. Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's disease.
Carella AM; Santini G; Santoro A; Coser P; Frassoni F; Martinengo M; Nati S; Congiu A; Giordano D; Cerri R
Eur J Cancer Clin Oncol; 1985 May; 21(5):607-13. PubMed ID: 3891365
[TBL] [Abstract][Full Text] [Related]
23. High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival.
Poen JC; Hoppe RT; Horning SJ
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):3-12. PubMed ID: 8823253
[TBL] [Abstract][Full Text] [Related]
24. Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation.
Philip T; Chauvin F; Armitage J; Bron D; Hagenbeek A; Biron P; Spitzer G; Velasquez W; Weisenburger DD; Fernandez-Ranada J
Blood; 1991 Apr; 77(7):1587-92. PubMed ID: 2009374
[TBL] [Abstract][Full Text] [Related]
25. High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease.
Jagannath S; Dicke KA; Armitage JO; Cabanillas FF; Horwitz LJ; Vellekoop L; Zander AR; Spitzer G
Ann Intern Med; 1986 Feb; 104(2):163-8. PubMed ID: 3511811
[TBL] [Abstract][Full Text] [Related]
26. Second autologous bone marrow transplantation in Hodgkin's disease.
Avalos BR; Copelan EA
Bone Marrow Transplant; 1993 Dec; 12(6):665-7. PubMed ID: 8136752
[TBL] [Abstract][Full Text] [Related]
27. Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support.
Hurd DD; Haake RJ; Lasky LC; Christiansen NP; McGlave PB; Bostrom B; Levine EG; Weisdorf DJ; Kim TH; Peterson BA
Med Pediatr Oncol; 1990; 18(6):447-53. PubMed ID: 1978232
[TBL] [Abstract][Full Text] [Related]
28. Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.
Carella AM; Carlier P; Congiu A; Occhini D; Nati S; Santini G; Pierluigi D; Giordano D; Bacigalupo A; Damasio E
Bone Marrow Transplant; 1991 Aug; 8(2):99-103. PubMed ID: 1718517
[TBL] [Abstract][Full Text] [Related]
29. Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation.
Colwill R; Crump M; Couture F; Danish R; Stewart AK; Sutton DM; Scott JG; Sutcliffe SB; Brandwein JM; Keating A
J Clin Oncol; 1995 Feb; 13(2):396-402. PubMed ID: 7844600
[TBL] [Abstract][Full Text] [Related]
30. Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantation.
Fernández-Jiménez MC; Canales MA; Ojeda E; de Bustos JG; Aguado MJ; Hernández-Navarro F
Haematologica; 1999 Nov; 84(11):1007-11. PubMed ID: 10553161
[TBL] [Abstract][Full Text] [Related]
31. [Autologous bone marrow transplantation for the treatment of malignant lymphoma in adults].
Da WM; Zhong JT; Huang YS
Zhonghua Nei Ke Za Zhi; 1992 Oct; 30(10):640-2, 660. PubMed ID: 1582346
[TBL] [Abstract][Full Text] [Related]
32. Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease.
Yahalom J; Gulati SC; Toia M; Maslak P; McCarron EG; O'Brien JP; Portlock CS; Straus DJ; Phillips J; Fuks Z
J Clin Oncol; 1993 Jun; 11(6):1062-70. PubMed ID: 8501492
[TBL] [Abstract][Full Text] [Related]
33. High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.
Jones RJ; Piantadosi S; Mann RB; Ambinder RF; Seifter EJ; Vriesendorp HM; Abeloff MD; Burns WH; May WS; Rowley SD
J Clin Oncol; 1990 Mar; 8(3):527-37. PubMed ID: 2307990
[TBL] [Abstract][Full Text] [Related]
34. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Santini G; Salvagno L; Leoni P; Chisesi T; De Souza C; Sertoli MR; Rubagotti A; Congiu AM; Centurioni R; Olivieri A; Tedeschi L; Vespignani M; Nati S; Soracco M; Porcellini A; Contu A; Guarnaccia C; Pescosta N; Majolino I; Spriano M; Vimercati R; Rossi E; Zambaldi G; Mangoni L; Rizzoli V
J Clin Oncol; 1998 Aug; 16(8):2796-802. PubMed ID: 9704732
[TBL] [Abstract][Full Text] [Related]
35. [Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger KH; Rühl U
Med Klin (Munich); 1992 Nov; 87(11):555-62. PubMed ID: 1281905
[TBL] [Abstract][Full Text] [Related]
36. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F
J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
[TBL] [Abstract][Full Text] [Related]
37. High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease.
Kessinger A; Bierman PJ; Vose JM; Armitage JO
Blood; 1991 Jun; 77(11):2322-5. PubMed ID: 1674890
[TBL] [Abstract][Full Text] [Related]
38. Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.
Vose JM; Sharp G; Chan WC; Nichols C; Loh K; Inwards D; Rifkin R; Bierman PJ; Lynch JC; Weisenburger DD; Kessinger A; Armitage JO
J Clin Oncol; 2002 May; 20(9):2344-52. PubMed ID: 11981006
[TBL] [Abstract][Full Text] [Related]
39. Clinical studies of autologous bone marrow transplantation in Hodgkin's disease.
Phillips GL; Reece DE
Clin Haematol; 1986 Feb; 15(1):151-66. PubMed ID: 3516487
[TBL] [Abstract][Full Text] [Related]
40. High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index.
O'Brien ME; Milan S; Cunningham D; Jones AL; Nicolson M; Selby P; Hickish T; Hill M; Gore ME; Viner C
Br J Cancer; 1996 May; 73(10):1272-7. PubMed ID: 8630292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
